Impact of Biosimilar Competition on Out-of-Pocket Costs for Biologics
Episode Summary
Biosimilar competition lowers out-of-pocket costs for Medicare patients on biologics, improving access, adherence, and outcomes while helping healthcare systems reduce spending on high-cost therapies.